|
[1]
|
Torres-Poveda, K., Ruiz-Fraga, I., Madrid-Marina, V., et al. (2019) High Risk HPV Infection Prevalence and Associated Cofactors: A Population-Based Study in Female ISSSTE Beneficiaries Attending the HPV Screening and Early Detection of Cervical Cancer Program. BMC Cancer, 19, Article No. 1205. [Google Scholar] [CrossRef] [PubMed]
|
|
[2]
|
俞佳敏, 邢燕. 系统免疫性疾病与宫颈病变[J]. 现代妇产科进展, 2021, 30(11): 863-865.
|
|
[3]
|
García-Carrasco, M., Mendoza-Pinto, C., Rojas-Villarraga, A., et al. (2019) Prevalence of Cervical HPV Infection in Women with Systemic Lupus Erythematosus: A Systematic Review and Meta-Analysis. Autoimmunity Reviews, 18, 184-191. [Google Scholar] [CrossRef] [PubMed]
|
|
[4]
|
Zard, E., Arnaud, L., Mathian, A., et al. (2014) Increased Risk of High Grade Cervical Squamous Intraepithelial Lesions in Systemic Lupus Erythematosus: A Meta-Analysis of the Liter-ature. Autoimmunity Reviews, 13, 730-735. [Google Scholar] [CrossRef] [PubMed]
|
|
[5]
|
Santana, I.U., Gomes Ado, N., Lyrio, L.D., et al. (2011) Sys-temic Lupus Erythematosus, Human Papillomavirus Infection, Cervical Pre-Malignant and Malignant Lesions: A Sys-tematic Review. Clinical Rheumatology, 30, 665-672. [Google Scholar] [CrossRef] [PubMed]
|
|
[6]
|
Rojo-Contreras, W., Olivas-Flores, E.M., Gamez-Nava, J.I., et al. (2012) Cervical Human Papillomavirus Infection in Mexican Women with Systemic Lupus Erythematosus or Rheuma-toid Arthritis. Lupus, 21, 365-372. [Google Scholar] [CrossRef] [PubMed]
|
|
[7]
|
王银浩, 谢通, 刘栩, 等. 女性系统性红斑狼疮患者HPV感染特点及疫苗安全性的研究现状[J]. 现代妇产科进展, 2018, 27(6): 462-464.
|
|
[8]
|
Bruni, L., Diaz, M., Castellsagué, X., et al. (2010) Cervical Human Papillomavirus Prevalence in 5 Continents: Meta- Analysis of 1 Million Women with Normal Cytological Findings. The Journal of Infectious Diseases, 202, 1789-1799. [Google Scholar] [CrossRef] [PubMed]
|
|
[9]
|
陈琦, 富诗岚, 徐慧芳, 等. 中国大陆女性HPV感染危险因素的Meta分析[J]. 中国微生态学杂志, 2022, 34(6): 657-664.
|
|
[10]
|
Amaral, J.L., Araújo, M.V., Dias, G.A., et al. (2017) Clinical and Epidemiological Study of Human Papillomavirus Infection in Women with Systemic Lupus Erythematosus in Eastern Brazilian Amazon. Acta Reumatologica Portuguesa, 42, 47-54.
|
|
[11]
|
Tam, L.S., Chan, A.Y., Chan, P.K., et al. (2004) Increased Prevalence of Squamous Intraepithelial Lesions in Systemic Lupus Erythematosus: Association with Human Papillomavirus Infection. Arthritis and Rheumatism, 50, 3619-3625. [Google Scholar] [CrossRef] [PubMed]
|
|
[12]
|
Tam, L.S., Chan, P.K., Ho, S.C., et al. (2010) Natural History of Cervical Papilloma Virus Infection in Systemic Lupus Erythematosus—A Prospective Cohort Study. The Journal of Rheumatol-ogy, 37, 330-340. [Google Scholar] [CrossRef] [PubMed]
|
|
[13]
|
Mendoza-Pinto, C., García-Carrasco, M., Vallejo-Ruiz, V., et al. (2017) Incidence of Cervical Human Papillomavirus Infection in Systemic Lupus Erythematosus Women. Lupus, 26, 944-951. [Google Scholar] [CrossRef] [PubMed]
|
|
[14]
|
李双, 孔北华. 人乳头瘤病毒疫苗临床应用中国专家共识(2021年版)解读[J]. 实用妇产科杂志, 2022, 38(11): 827-831.
|
|
[15]
|
Foster, E., Malloy, M.J., Jokubaitis, V.G., et al. (2020) Increased Risk of Cervical Dysplasia in Females with Autoimmune Conditions—Results from an Australia Data-base Linkage Study. PLOS ONE, 15, e0234813. [Google Scholar] [CrossRef] [PubMed]
|
|
[16]
|
张延玲, 高燕云. 系统免疫性疾病女性患者宫颈癌及癌前病变的风险研究[J]. 中国性科学, 2017, 26(6): 38-41.
|
|
[17]
|
Rees, F., Doherty, M., Grainge, M.J., et al. (2017) The Worldwide Incidence and Prevalence of Systemic Lupus Erythematosus: A Systematic Review of Epidemiological Stud-ies. Rheumatology (Oxford, England), 56, 1945-1961. [Google Scholar] [CrossRef] [PubMed]
|
|
[18]
|
Feldman, C.H., Liu, J., Feldman, S., et al. (2017) Risk of High-Grade Cervical Dysplasia and Cervical Cancer in Women with Systemic Lupus Erythematosus Receiving Immu-nosuppressive Drugs. Lupus, 26, 682-689. [Google Scholar] [CrossRef] [PubMed]
|
|
[19]
|
Dreyer, L., Faurschou, M., Mogensen, M., et al. (2011) High In-cidence of Potentially Virus-Induced Malignancies in Systemic Lupus Erythematosus: A Long-Term Follow-Up Study in a Danish Cohort. Arthritis and Rheumatism, 63, 3032-3037. [Google Scholar] [CrossRef] [PubMed]
|
|
[20]
|
Cocchio, S., Bertoncello, C., Baldovin, T., et al. (2020) Awareness of HPV and Drivers of HPV Vaccine Uptake among University Students: A Quantitative, Cross-Sectional Study. Health & Social Care in the Community, 28, 1514-1524. [Google Scholar] [CrossRef] [PubMed]
|
|
[21]
|
狄娜, 刘应南, 张建欣, 等. HPV知晓度和HPV疫苗接受度问卷调查情况研究进展[J]. 中国全科医学, 2020, 23(13): 1675-1679.
|
|
[22]
|
David, E., Roy, P., Belot, A., et al. (2022) Human Papilloma Virus Vaccination in Patients with Rheumatic Diseases in France: A Study of Vaccination Coverage and Driv-ers of Vaccination. Journal of Clinical Medicine, 11, Article No. 4137. [Google Scholar] [CrossRef] [PubMed]
|
|
[23]
|
Dhar, J.P., Essenmacher, L., Dhar, R., et al. (2019) Lack of Uptake of Prophylactic Human Papilloma Virus Vaccine among Women with Systemic Lupus Erythematosus Seen at a Regional Medical Center. Journal of Clinical Rheumatology: Practical Reports on Rheumatic & Musculoskeletal Diseases, 25, 348-350. [Google Scholar] [CrossRef]
|
|
[24]
|
Chehab, G., Richter, J.G., Brinks, R., et al. (2018) Vaccina-tion Coverage in Systemic Lupus Erythematosus—A Cross- Sectional Analysis of the German Long-Term Study (LuLa Cohort). Rheumatology (Oxford, England), 57, 1439-1447. [Google Scholar] [CrossRef] [PubMed]
|
|
[25]
|
Andreoli, L., Bertsias, G.K., Agmon-Levin, N., et al. (2017) EULAR Recommendations for Women’s Health and the Management of Family Planning, Assisted Reproduction, Preg-nancy and Menopause in Patients with Systemic Lupus Erythematosus and/or Antiphospholipid Syndrome. Annals of the Rheumatic Diseases, 76, 476-485. [Google Scholar] [CrossRef] [PubMed]
|
|
[26]
|
Furer, V., Rondaan, C., Heijstek, M.W., et al. (2020) 2019 Update of EULAR Recommendations for Vaccination in Adult Patients with Autoimmune Inflammatory Rheumatic Dis-eases. Annals of the Rheumatic Diseases, 79, 39-52. [Google Scholar] [CrossRef] [PubMed]
|
|
[27]
|
Setiawan, D., Luttjeboer, J., Pouwels, K.B., et al. (2017) Immunogenicity and Safety of Human Papillomavirus (HPV) Vaccination in Asian Populations from Six Countries: A Meta-Analysis. Japanese Journal of Clinical Oncology, 47, 265-276. [Google Scholar] [CrossRef] [PubMed]
|
|
[28]
|
Grein, I.H., Groot, N., Lacerda, M.I., et al. (2016) HPV Infection and Vaccination in Systemic Lupus Erythematosus Patients: What We Really Should Know. Pediatric Rheumatology Online Journal, 14, Article No. 12. [Google Scholar] [CrossRef] [PubMed]
|
|
[29]
|
Johnson, C.A., James, D., Marzan, A., et al. (2019) Cervical Cancer: An Overview of Pathophysiology and Management. Seminars in Oncology Nursing, 35, 166-174. [Google Scholar] [CrossRef] [PubMed]
|
|
[30]
|
Moscicki, A.B., Flowers, L., Huchko, M.J., et al. (2019) Guide-lines for Cervical Cancer Screening in Immunosuppressed Women without HIV Infection. Journal of Lower Genital Tract Disease, 23, 87-101. [Google Scholar] [CrossRef]
|
|
[31]
|
Mok, C.C., Ho, L.Y., Fong, L.S., et al. (2013) Immunogen-icity and Safety of a Quadrivalent Human Papillomavirus Vaccine in Patients with Systemic Lupus Erythematosus: A Case-Control Study. Annals of the Rheumatic Diseases, 72, 659-664. [Google Scholar] [CrossRef] [PubMed]
|
|
[32]
|
Mok, C.C., Ho, L.Y., Fong, L.S., et al. (2013) Immuno-genicity and Safety of a Quadrivalent Human Papillomavirus Vaccine in Patients with Systemic Lupus Erythematosus: A Case-Control Study. Annals of the Rheumatic Diseases, 72, 659-664. [Google Scholar] [CrossRef] [PubMed]
|
|
[33]
|
Infante, V., Miyaji, K.T., Soarez, P.C., et al. (2021) Sys-tematic Review and Meta-Analysis of HPV Vaccination in Women with Systemic Lupus Erythematosus (SLE). Expert Review of Vaccines, 20, 309-318. [Google Scholar] [CrossRef] [PubMed]
|
|
[34]
|
Lu, B., Kumar, A., Castellsagué, X., et al. (2011) Efficacy and Safety of Prophylactic Vaccines against Cervical HPV Infection and Diseases among Women: A Systematic Review & Meta-Analysis. BMC Infectious Diseases, 11, Article No. 13. [Google Scholar] [CrossRef] [PubMed]
|
|
[35]
|
Slade, B.A., Leidel, L., Vellozzi, C., et al. (2009) Postlicensure Safety Surveillance for Quadrivalent Human Papillomavirus Recombinant Vaccine. JAMA, 302, 750-757. [Google Scholar] [CrossRef] [PubMed]
|
|
[36]
|
Rotstein Grein, I.H., Pinto, N.F., Lobo, A., et al. (2020) Safety and Immunogenicity of the Quadrivalent Human Papillomavirus Vaccine in Patients with Childhood Systemic Lupus Ery-thematosus: A Real-World Interventional Multi-Centre Study. Lupus, 29, 934-942. [Google Scholar] [CrossRef] [PubMed]
|
|
[37]
|
Agmon-Levin, N., Paz, Z., Israeli, E., et al. (2009) Vaccines and Autoimmunity. Nature Reviews Rheumatology, 5, 648-652. [Google Scholar] [CrossRef] [PubMed]
|
|
[38]
|
Israeli, E., Agmon-Levin, N., Blank, M., et al. (2011) Macrophagic Myofaciitis a Vaccine (Alum) Autoimmune-Related Disease. Clinical Reviews in Allergy & Immunology, 41, 163-168. [Google Scholar] [CrossRef] [PubMed]
|
|
[39]
|
Guo, Y., Shi, L., Hong, H., et al. (2013) Studies on Abacavir-Induced Hypersensitivity Reaction: A Successful Example of Translation of Pharmacogenetics to Personalized Medicine. Science China Life Sciences, 56, 119-124. [Google Scholar] [CrossRef] [PubMed]
|
|
[40]
|
Bragazzi, N.L., Bridgewood, C., Sharif, K., et al. (2019) HPV Vaccines and Lupus: Current Approaches towards Preventing Adverse Immune Cross-Reactivity. Expert Review of Vac-cines, 18, 31-42. [Google Scholar] [CrossRef] [PubMed]
|
|
[41]
|
Curry, S.J., Krist, A.H., Owens, D.K., et al. (2018) Screen-ing for Cervical Cancer: US Preventive Services Task Force Recommendation Statement. JAMA, 320, 674-686. [Google Scholar] [CrossRef] [PubMed]
|
|
[42]
|
(2016) Practice Bulletin No. 167: Gynecologic Care for Women and Adolescents with Human Immunodeficiency Virus. Obstetrics and Gynecology, 128, e89-e110.
|